Oncolys Biopharma Inc 4588.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
574.00quote price arrow down-16.00 (-2.71%)
Volume
47,100
52 week range
466.00 - 1,938.00
Loading...
  • Open587.00
  • Day High587.00
  • Day Low571.00
  • Prev Close590.00
  • 52 Week High1,938.00
  • 52 Week High Date06/25/21
  • 52 Week Low466.00
  • 52 Week Low Date01/28/22

Key Stats

  • Market Cap75.79M
  • Shares Out17.33M
  • 10 Day Average Volume86,842.86
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change8.71

KEY STATS

  • Open587.00
  • Day High587.00
  • Day Low571.00
  • Prev Close590.00
  • 52 Week High1,938.00
  • 52 Week High Date06/25/21
  • 52 Week Low466.00
  • 52 Week Low Date01/28/22
  • Market Cap75.79M
  • Shares Out17.33M
  • 10 Day Average Volume86,842.86
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change8.71

RATIOS/PROFITABILITY

  • EPS (TTM)-92.30
  • P/E (TTM)-6.22
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Oncolys Biopharma Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Oncolys BioPharma Inc. is a biopharmaceutical company. The Company operates in two business segments. Pharmaceutical business segment is engaged in the research, development, manufacture and marketing of pharmaceuticals. Diagnostic reagents business segment is engaged in the research, development, manufacture and marketing of diagnostic reagents and equipment, as well as the provision of inspection service. The Company's main pipeline includes OBP-301 (Telomelysin), an...
Yasuo Urata
President, Representative Director
Address
Toranomon Towers Office
4-1-28, Toranomon
Minato-ku, TKY
105-0001
Japan